MedTrace Logo

Lactoferrin Alone ,Iron Alone Vs Lactoferrin Plus Iron for Treatment of Iron Deficiency Anemia

NCT06590831 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 399

Last updated 2024-09-19

No results posted yet for this study

Summary

Iron deficiency (ID) and iron deficiency anemia (IDA) are the most common iron disorders throughout the world.

ID and IDA, particularly caused by increased iron requirements during pregnancy; represent a high risk for preterm delivery, fetal growth retardation, low birth weight, and inferior neonatal health. These pregnancy complications are thought to occur because of an increased iron requirement, related to enhanced blood volume and development of the fetoplacental unit.

Conditions

Interventions

DRUG

Lactoferrin

to compare between efficacy of lactoferrin alone and lactoferrin with iron for treatment of iron deficiency anemia during 3rd trimester of pregnancy

Sponsors & Collaborators

  • Al-Azhar University

    collaborator OTHER

  • Egymedicalpedia

    lead INDUSTRY

Principal Investigators

  • Ahmed Ali Nasr, Professor · Al-Azhar University, Faculty of medicine, Assuit.

  • Medhat kamel fathy, Lecturer · Al-Azhar University, Faculty of medicine, Assuit.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-10
Primary Completion
2024-06-01
Completion
2024-06-10

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06590831 on ClinicalTrials.gov